| abstract |
Compounds effective to inhibit the replication of hepatitis C virus ("HCV"), for example, {(2S,3R)-1-[(2S)2{5[(2R,5R)1{3,5difluoro4- [4(4-fluorophenyl)piperidin-1yl]phenyl}5-(6fluoro-2{(2S)1[N-(methoxycarbonyl)Omethyl-L-threonyl]pyrrolidin2-yl}1H-benzimidazol5-yl)pyrrolidin-2-yl] Methyl 6-fluoro-1H-benzimidazol2-yl}pyrrolidin-1-yl]3methoxy-1oxobutan-2-yl}carbamate, or pharmaceutically acceptable salts thereof, compositions comprising them and use thereof for preparing a useful medicine to treat an HCV infection. |